PI Spotlight: Pasquale Perrone-Filardi on JACC 2025 Feb

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
[Full abstract] Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry), JACC 2025 Feb, 85 (5) 536–540 https://www.jacc.org/doi/10.1016/j.jacc.2024.10.106

[Chapters]
00:04 - Highlights
00:31 - Key notes by Guest Editor
01:13 - What makes the CHOLINET Registry special?
02:55 - What are the results of the CHOLINET Registry
07:00 - What is the mechanism of action of inclisiran, and how much does it cost?
08:37 – In the future, can inclisiran be prescribed without restrictions?
11:06 – Invitation for questions
11:15 – About PI Spotlight
11:45 – P2P ad

[Q&A] If you have any interesting comments, please post them in the comment box below. The PI will respond and have the Spotlight channel secretariat post the feedback on his behalf.

[Channel] PI Spotlight in Cardiology: Who’s Next? https://www.youtube.com/playlist?list=PLg8ipm7zYAtVaMD0CFbSnN4LRIwkDhIEr

[Disclosure] This video is an independent report organized by PeerMD without any influence from 3rd party. Powered by Peer-To-Peer technology (P2P), this video is quickly and broadly promoted to healthcare professionals worldwide in over 50 countries. This video is intended for internal training exclusively provided to healthcare professionals (HCPs). If you are not an HCP, you should stop watching this video immediately and shall be liable for the consequences and/or damages resulting from your misrepresentation.

[Technology Partner] P2P videos are watched by tens of thousands of healthcare peers worldwide, so you may use our platform to promote your papers, cases, and even conference announcements. Here at P2P, you are not only a spectator but also a contributor. Please register at www.p2pmd.net to access other P2P videos.
Category
Cardiology
Be the first to comment

Up Next